Effect of COVID 19 on Pre-existent Hypertension and its impact on unmasking new onset hypertension in recovered cases: A Single center Experience

Devang Kulkarni, Resident, Internal Medicine, MIMSR Medical College, Latur India
Shital Patil, Professor, Pulmonary Medicine Venkatesh Hospital and Critical Care center, Latur, IndiaFollow
Anant Kulkarni, Professor, Internal medicine, KMMC, Kanyakumari, India
Gajanan Gondhali, Professor, Pulmonary Medicine, MIMSR Medical College, Latur India

Article Type

Original Study

Subject Area

Cardiovascular and Blood Diseases

Abstract

Introduction New onset hypertension and aggravation of hypertension during the post-COVID period are issues of concern having very limited data published on them. Hence, the current study was conducted with the aim of studying the blood pressure profiles as new onset hypertension, preexistent hypertension and an aggravation of preexistent hypertension in post-COVID patients. Methods Retrospective cohort study conducted between October 2021 to March 2022, included 800 post-COVID patients above 18 years of age treated at the DCC (dedicated covid care center) irrespective of their disease severity and comorbidity after a valid written consent. All the study cases were followed after six months of discharge from hospital. Protocolled recording of covariates such as blood pressure, anthropometric indices, ECG, blood sugar, lipid profile and uric acid were done at entry point. Retrospective data collection of indoor records was done such CT Severity assessment as mild (score15); inflammatory markers IL-6, Ferritin, CRP, LDH and D-dimer, interventions used during hospitalization such as oxygen supplementation and oxygen plus BIPAP/NIV. Statistical analysis was done by using chi test. Results In study of 800 post covid cases, preexistent hypertension in 10% (80/800), new onset hypertension in 8.5% (68/800), aggravation of preexistent hypertension in 47.5% (38/80) cases. Significant association was observed between interventions used as hypertension profile such as cases with oxygen requirement new onset HTN 32/68 (47.05%), preexistent hypertension in 10/42 (23.80%), aggravation of preexistent hypertension in 16/38 (42.10%) and oxygen plus BIPAP/NIV requirement in new onset HTN 27/68 (39.70%), preexistent hypertension in 10/42 (23.80%), aggravation of preexistent hypertension in 16/38 (42.10%) cases [p

IRB Number

2021-03824

Keywords

COVID-19; Hypertension; Post-COVID; Inflammatory makers; Uric Acid

Recommended Citation

Kulkarni, Devang; Patil, Shital; Kulkarni, Anant; and Gondhali, Gajanan (2024) "Effect of COVID 19 on Pre-existent Hypertension and its impact on unmasking new onset hypertension in recovered cases: A Single center Experience," Journal of Medicine in Scientific Research: Vol. 8: Iss. 2, Article 9.
DOI: https://doi.org/10.59299/2537-0928.1435